AnaptysBio (NASDAQ: ANAB) investor files Rule 144 to sell 2,235 shares

Rhea-AI Filing Summary

AnaptysBio shareholder Paul F. Lizzul filed a Rule 144 notice to sell 2,235 shares of the company’s common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC, with an aggregate market value of 98138.85, and an approximate sale date of 01/07/2026 on the NASDAQ.

The shares were acquired as restricted stock units from the issuer and paid for in cash on 01/07/2026. The filing notes that 27,688,470 common shares were outstanding. Over the prior three months, Lizzul sold 4,219 common shares on 01/05/2026 for gross proceeds of 189644.05 and 1,500 common shares on 12/22/2025 for gross proceeds of 75000.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2235	98138.85	27688470	01/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/07/2026	Restricted Stock Units	Issuer			2235	01/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paul F Lizzul 10770 Wateridge Circle, Suite 210 San Diego CA 92121	Common	01/05/2026	4219	189644.05
Paul F Lizzul 10770 Wateridge Circle, Suite 210 San CA 92121	Common	12/22/2025	1500	75000

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ANAB Form 144 filing by Paul F. Lizzul disclose?

The filing shows that shareholder Paul F. Lizzul intends to sell 2,235 shares of AnaptysBio common stock under Rule 144, using Morgan Stanley Smith Barney LLC as broker.

How many AnaptysBio (ANAB) shares are covered by this Form 144?

The notice covers a proposed sale of 2,235 shares of AnaptysBio common stock, with an aggregate market value of 98138.85.

When is the Rule 144 sale for ANAB shares expected to occur?

The approximate date of sale listed is 01/07/2026, with the shares to be sold on the NASDAQ exchange.

How were the ANAB shares in this Form 144 acquired?

The 2,235 shares were acquired on 01/07/2026 as restricted stock units from the issuer, with the purchase price paid in cash.

What recent sales of AnaptysBio shares has Paul F. Lizzul reported?

Over the past three months, Lizzul sold 4,219 common shares on 01/05/2026 for gross proceeds of 189644.05 and 1,500 common shares on 12/22/2025 for gross proceeds of 75000.

How many AnaptysBio shares were outstanding in this Form 144?

The filing states that 27,688,470 shares of AnaptysBio common stock were outstanding.

What representation does the seller make in this ANAB Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.